JETEMA, Co., Ltd. (KOSDAQ:216080)
9,690.00
+330.00 (3.53%)
At close: Feb 6, 2026
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 348.91 billion as of February 6, 2026. Its market cap has increased by 32.12% in one year.
Market Cap
348.91B
Enterprise Value
454.99B
Revenue
75.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,690.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 348.91B, an increase of 170.25%. That is a compound annual growth rate of 17.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 348.91B | 58.33% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 566.62B |
| SillaJen | 523.51B |
| BINEX | 480.90B |
| Anterogen.Co.,Ltd. | 401.24B |
| Bioneer | 336.05B |
| Helixmith | 276.74B |
| EASY BIO,Inc. | 248.78B |
| HLB Therapeutics | 247.25B |